News In Brief
This article was originally published in The Gray Sheet
Orthofix unloads sports medicine unit. Baxter completes Sigma purchase. Edwards Lifesciences’ Sapien update. More news briefs.
You may also be interested in...
Baxter is augmenting its troubled infusion pump franchise with Sigma's Spectrum smart pump technology under a $100 million licensing agreement announced April 15
Drawing on 24 years as a legislator and another 16 years as a leading lobbyist for biopharma, Jim Greenwood sees an opportunity for industry to put drug pricing ‘behind us’ with a legislative compromise.
SENZA PDN showed Nevro's HF10 spinal cord stimulation therapy provided sustained relief to patients with painful diabetic neuropathy. Results of a separate trial showed HF10 improved outcomes in patients with non-surgical refractory back pain.